ABK Ambac Financial Grp. Common Stock

Notice is hereby given that Finkelstein Thompson LLP has filed a class action lawsuit in the United States District Court for the Southern District of New York on behalf of purchasers of Ambac Financial Group, Inc. (�Ambac�) (NYSE:ABK) common stock during the period between October 19, 2005 and November 26, 2007 (the �Class Period�). The complaint charges Ambac and certain of its officers and directors with violations of the Securities Exchange Act of 1934. Ambac is a holding company whose subsidiaries provide financial guarantee products and other financial services to clients in both the public and private sectors around the world. The complaint alleges that during the Class Period, defendants issued materially false and misleading statements regarding the Company�s business and financial results related to its financial exposure on collateralized debt obligations (�CDO�) contracts. Specifically, the complaint alleges that defendants misrepresented and concealed the material facts that: (i) the Company lacked requisite internal controls to ensure that the Company�s underwriting standards and its internal rating system for its CDO contracts were adequate, and, as a result, the Company�s projections and reported results issued during the Class Period were based upon defective assumptions and/or manipulated facts; (ii) the Company�s financial statements were materially misstated due to its failure to properly account for its mark-to-market losses; (iii) given the deterioration and the increased volatility in the mortgage market, the Company would be forced to tighten its underwriting standards related to its asset-backed securities, which would have a direct material negative impact on its premium production going forward; (iv) the Company had far greater exposure to anticipated losses and defaults related to its CDO contracts containing subprime loans, including even highly rated CDOs, than it had previously disclosed; (v) the Company had far greater exposure to a potential ratings downgrade from one of the credit ratings agencies than it had previously disclosed; and (vi) defendants� Class Period statements about the Company�s selective underwriting practices during the 2005 through 2007 timeframe related to its CDOs backed by subprime assets were patently false; as the Company�s underwriting standards were at best aggressive and at a minimum were completely inadequate. As the truth began to be disclosed, shares of Ambac common stock plummeted, causing substantial losses to investors. Plaintiff seeks to recover damages on behalf of all purchasers of Ambac common stock during the Class Period (the �Class�) and is represented by Finkelstein Thompson LLP. Finkelstein Thompson LLP has spent over three decades delivering outstanding representation to institutional and individual clients in connection with securities and other finance-related litigation, and has been appointed as lead or co-lead counsel in dozens of shareholder class actions. Indeed, in the past decade, the firm has served leadership roles in cases that have recovered over $1 billion for investors and consumers. If you wish to serve as lead plaintiff, you must move the Court no later than March 17, 2008. A lead plaintiff is a class member that acts on behalf of other class members in directing the litigation. Although your ability to share in any recovery is not affected by the decision whether or not to seek appointment as a lead plaintiff, lead plaintiffs make important decisions which could affect the overall recovery for class members, including decisions concerning settlement. The securities laws require the Court to consider the class member(s) with the largest financial interest as presumptively the most adequate lead plaintiff(s). If you wish to discuss this action or have any questions concerning this notice or your rights or interests, please contact plaintiff�s counsel, Donald J. Enright or Elizabeth K. Tripodi at (877) 337-1050, or via e-mail at contact@finkelsteinthompson.com. To learn more about this case and Finkelstein Thompson LLP, please visit www.finkelsteinthompson.com.